Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Changes to CHS 2020 Eye Scheme announced
The changes will be effective from 1 January 2020.
Move follows consultation with the Eye Panel Working Party

The Kennel Club and the BVA has announced changes to the Canine Health Schemes (CHS) Eye Scheme for 2020.

The move follows consultation with the Eye Panel Working Party, and will see the removal of Schedule B. Instead, the CHS ‘Sightings report’, which records and monitors evidence of conditions and abnormalities, will be used to add and remove breeds to and from Schedule A.

In a press release, the Kennel Club said: ‘Where evidence of new and emerging conditions has been noted via the sightings reports, breeds may be considered for addition to Schedule A, and where no reports of affected dogs have been noted for a period of five years, breeds may be considered for removal from Schedule A.

‘Due to evidence of an established condition, the following breeds currently listed on Schedule B will be added to Schedule A: Border Collie (Goniodysgenesis/primary glaucoma), French Bulldog (Hereditary cataracts early onset), Hungarian Vizsla (Generalised progressive retinal atrophy), Papillon (Generalised progressive retinal atrophy), and Golden Retriever (Goniodysgenesis/primary glaucoma).

‘Remaining breeds currently listed on Schedule B have had very few reports of associated eye conditions and so will no longer be listed, as evidence suggests that the breed is not, at this time, predisposed to the condition.’

The changes, which also include wording on the eye certificates, will be effective from 1 January 2020.

Bill Lambert, Senior Health and Welfare Manager at the Kennel Club commented: “Collaboratively with the BVA and the Eye Panel Working Party, we have agreed that Schedule B is removed as it no longer serves a reasonable purpose. We now have improved ways to more effectively monitor eye conditions in all breeds with an annual sightings report, which has run alongside the scheme for five years now.

“Many breeders will welcome the opportunity to participate in the scheme and have the results published on the Kennel Club Health Tests Results Finder regardless of whether their breed appears on Schedule A. Any abnormalities collated in this sightings report will be reviewed annually by the Eye Panel Working Party, providing continual surveillance of the incidence of any new and emerging conditions in any breed, and assisting breeders in making sensible breeding decisions that promote good dog health.”

BVA president, Daniella Dos Santos added: “The annual sightings report means we now have five years of data on which dogs are most affected by hereditary eye diseases. We hope the removal of Schedule B will make it easier for breeders to recognise and test the breeds that are most likely to be affected by these diseases and we’ll continue to encourage routine eye screening for dogs of any breed, both purebred and crossbreed, both to ensure we have the most accurate data possible and to safeguard the health of the dogs involved.”

For more information about the updates, visit https://www.thekennelclub.org.uk/eye-scheme-questions

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.